TherapeuticsMD, Inc. (NASDAQ:TXMD – Get Free Report) was the recipient of a significant drop in short interest in the month of March. As of March 15th, there was short interest totalling 170,200 shares, a drop of 19.1% from the February 28th total of 210,500 shares. Approximately 1.5% of the shares of the stock are sold short. Based on an average daily volume of 536,100 shares, the short-interest ratio is presently 0.3 days.
TherapeuticsMD Stock Performance
TXMD stock traded down $0.05 during midday trading on Wednesday, hitting $0.93. 55,765 shares of the stock were exchanged, compared to its average volume of 152,475. TherapeuticsMD has a fifty-two week low of $0.70 and a fifty-two week high of $2.44. The stock’s 50-day moving average price is $0.96 and its 200-day moving average price is $1.24.
Analyst Ratings Changes
Separately, StockNews.com began coverage on shares of TherapeuticsMD in a report on Tuesday. They issued a “hold” rating for the company.
About TherapeuticsMD
TherapeuticsMD, Inc operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.
Featured Stories
- Five stocks we like better than TherapeuticsMD
- 3 Small Caps With Big Return Potential
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- 3 REITs to Buy and Hold for the Long Term
- The 3 Most Talked About Investments on WallStreetBets Right Now
- How to Invest in Biotech Stocks
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for TherapeuticsMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TherapeuticsMD and related companies with MarketBeat.com's FREE daily email newsletter.
